Schwann cell-derived Apolipoprotein D controls the dynamics of post-injury myelin recognition and degradation

Frontiers in Cellular Neuroscience

Volumn 8, Issue November, 2014, Pages

  García Mateo, Nadia ^a   Ganfornina, Maria D ^a   Montero, Olimpio ^b   Gijón, Miguel A ^c   Murphy, Robert C ^c   Sanchez, Diego ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b CSIC   (Spain)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Arachidonic acid; Lipocalin; Lysophosphatidylcholine; Macrophage; Myelin degradation; Myelin phagocytosis; Sciatic nerve

Indexed keywords

APOLIPOPROTEIN D; ARACHIDONIC ACID; CD11B ANTIGEN; CYTOSOLIC PHOSPHOLIPASE A2; GALECTIN 3; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN; PROTEIN S 100; TRYPTOPHAN; TUMOR NECROSIS FACTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL LABELING; CONTROLLED STUDY; CRUSH TRAUMA; DENERVATION; EX VIVO STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; GLIA CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTY; IN VIVO STUDY; MACROPHAGE ACTIVATION; MASS SPECTROMETRY; MOUSE; MYELINATION; NERVE INJURY; NERVE REGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN ISOLATION; RECEPTOR BINDING ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; SCIATIC NERVE; WALLERIAN DEGENERATION;

EID: 84925674923     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00374     Document Type: Article

References (50)

1. Arthur-Farraj, P. J., Latouche, M., Wilton, D., Quintes, A., Chabrol, E., Banerjee, A., et al. (2012). c-jun reprograms schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron 75, 633-647. doi: 10.1016/j.neuron.2012.06.021.
2. Bajo-Grañeras, R., Ganfornina, M. D., Martin-Tejedor, E., and Sanchez, D. (2011). Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems. Glia 59, 1551-1566. doi: 10.1002/glia.21200.
3. Bhatia, S., Knoch, B., Wong, J., Kim, W. S., Else, P. L., Oakley, A. J., et al. (2011). Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D implications for lipid antioxidant activity and Alzheimer's disease. Biochem. J. 442, 713-721. doi: 10.1016/j.plefa.2003.08.014.
4. Bligh, E. G., and Dyer, W. J. (1959). A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917. doi: 10.1139/o59-099.
5. Bogie, J. F., Jorissen, W., Mailleux, J., Nijland, P. G., Zelcer, N., Vanmierlo, T., et al. (2013). Myelin alters the inflammatory phenotype of macrophages by activating PPARs. Acta Neuropathol. Commun. 1:43. doi: 10.1186/2051-5960-1-43.
6. Bolin, L. M., Verity, A. N., Silver, J. E., Shooter, E. M., and Abrams, J. S. (1995). Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J. Neurochem. 64, 850-858. doi: 10.1046/j.1471-4159.1995.64020850.x.
7. Boyles, J. K., Notterpek, L. M., and Anderson, L. J. (1990). Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. J. Biol. Chem. 265, 17805-17815.
8. Chattopadhyay, S., and Shubayev, V. I. (2009). MMP-9 controls Schwann cell proliferation and phenotypic remodeling via IGF-1 and ErbB receptor-mediated activation of MEK/ERK pathway. Glia 57, 1316-1325. doi: 10.1002/glia.20851.
9. Dassati, S., Waldner, A., and Schweigreiter, R. (2014). Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Neurobiol. Aging 35, 1632-1642. doi: 10.1016/j.neurobiolaging.2014.01.148.
10. Ganfornina, M. D., Do Carmo, S., Lora, J. M., Torres-Schumann, S., Vogel, M., Allhorn, M., et al. (2008). Apolipoprotein D. is involved in the mechanisms regulating protection from oxidative stress. Aging Cell 7, 506-515. doi: 10.1111/j.1474-9726.2008.00395.x.
11. Ganfornina, M. D., Do Carmo, S., Martinez, E., Tolivia, J., Navarro, A., Rassart, E., et al. (2010). ApoD a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury. Glia 58, 1320-1334. doi: 10.1002/glia.21010.
12. Ganfornina, M. D., Sanchez, D., Pagano, A., Tonachini, L., Descalzi-Cancedda, F., and Martinez, S. (2005). Molecular characterization and developmental expression pattern of the chicken apolipoprotein D gene: implications for the evolution of vertebrate lipocalins. Dev. Dyn. 232, 191-199. doi: 10.1002/dvdy.20193.
13. Gaudet, A. D., Popovich, P. G., and Ramer, M. S. (2011). Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J. Neuroinflammation 8:110. doi: 10.1186/1742-2094-8-110.
14. Gregson, N. A., and Hall, S. M. (1973). A quantitative analysis of the effects of the intraneural injection of lysophosphatidyl choline. J. Cell Sci. 13, 257-277.
15. Hall, S. M., and Gregson, N. A. (1971). The in vivo and ultrastructural effects of injection of lysophosphatidyl choline into myelinated peripheral nerve fibres of the adult mouse. J. Cell Sci. 9, 769-789.
16. Huebner, E. A., and Strittmatter, S. M. (2009). Axon regeneration in the peripheral and central nervous systems. Results Probl. Cell Differ. 48, 339-351. doi: 10.1007/400_2009_19.
17. Hull-Thompson, J., Muffat, J., Sanchez, D., Walker, D. W., Benzer, S., Ganfornina, M. D., et al. (2009). Control of metabolic homeostasis by stress signaling is mediated by the lipocalin NLaz. PLoS Genet. 5:e1000460. doi: 10.1371/journal.pgen.1000460.
18. Iwatsuki, K., Arai, T., Ota, H., Kato, S., Natsume, T., Kurimoto, S., et al. (2013). Targeting anti-inflammatory treatment can ameliorate injury-induced neuropathic pain. PLoS ONE 8:e57721. doi: 10.1371/journal.pone.0057721.
19. Jahn, O., Tenzer, S., and Werner, H. B. (2009). Myelin proteomics: molecular anatomy of an insulating sheath. Mol. Neurobiol. 40, 55-72. doi: 10.1007/s12035-009-8071-2.
20. Jessen, K. R., Morgan, L., Stewart, H. J., and Mirsky, R. (1990). Three markers of adult non-myelin-forming Schwann cells, 217c(Ran-1), A5E3 and GFAP: development and regulation by neuron-Schwann cell interactions. Development 109, 91-103.
21. Kleinschnitz, C., Brinkhoff, J., Zelenka, M., Sommer, C., and Stoll, G. (2004). The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J. Neuroimmunol. 149, 77-83. doi: 10.1016/j.jneuroim.2003.12.013.
22. Kobayashi, H., Chattopadhyay, S., Kato, K., Dolkas, J., Kikuchi, S., Myers, R. R., et al. (2008). MMPs initiate Schwann cell-mediated, MBP degradation and mechanical nociception after nerve damage. Mol. Cell. Neurosci. 39, 619-627. doi: 10.1016/j.mcn.2008.08.008.
23. Koeppen, A. H. (2004). Wallerian degeneration: history and clinical significance. J. Neurol. Sci. 220, 115-117. doi: 10.1016/j.jns.2004.03.008.
24. Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408. doi: 10.1006/meth.2001.1262.
25. Lopez-Vales, R., Navarro, X., Shimizu, T., Baskakis, C., Kokotos, G., Constantinou-Kokotou, V., et al. (2008). Intracellular phospholipase A(2) group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury. Brain 131(Pt 10), 2620-2631. doi: 10.1093/brain/awn188.
26. Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., and Locati, M. (2013). Macrophage plasticity and polarization in tissue repair and remodelling. J. Pathol. 229, 176-185. doi: 10.1002/path.4133.
27. Martini, R., Fischer, S., Lopez-Vales, R., and David, S. (2008). Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 56, 1566-1577. doi: 10.1002/glia.20766.
28. Morais Cabral, J. H., Atkins, G. L., Sanchez, L. M., Lopez-Boado, Y. S., Lopez-Otin, C., and Sawyer, L. (1995). Arachidonic acid binds to apolipoprotein D: implications for the protein's function. FEBS Lett. 366, 53-56. doi: 10.1016/0014-5793(95)00484-Q.
29. Municio, C., Alvarez, Y., Montero, O., Hugo, E., Rodriguez, M., Domingo, E., et al. (2013). The response of human macrophages to beta-glucans depends on the inflammatory milieu. PLoS ONE 8:e62016. doi: 10.1371/journal.pone.0062016.
30. Murakami, M., Nakatani, Y., Atsumi, G., Inoue, K., and Kudo, I. (1997). Regulatory functions of phospholipase A2. Crit. Rev. Immunol. 17, 225-283. doi: 10.1615/CritRevImmunol.v17.i3-4.10.
31. Murugesan, G., Sandhya Rani, M. R., Gerber, C. E., Mukhopadhyay, C., Ransohoff, R. M., Chisolm, G. M., et al. (2003). Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines. J. Mol. Cell. Cardiol. 35, 1375-1384. doi: 10.1016/j.yjmcc.2003.08.004.
32. Norton, W. T., and Poduslo, S. E. (1973). Myelination in rat brain: method of myelin isolation. J. Neurochem. 21, 749-757. doi: 10.1111/j.1471-4159.1973.tb07519.x.
33. Ojala, P. J., Hermansson, M., Tolvanen, M., Polvinen, K., Hirvonen, T., Impola, U., et al. (2006). Identification of alpha-1 acid glycoprotein as a lysophospholipid binding protein: a complementary role to albumin in the scavenging of lysophosphatidylcholine. Biochemistry 45, 14021-1431. doi: 10.1021/bi061657l.
34. Reichert, F., Slobodov, U., Makranz, C., and Rotshenker, S. (2001). Modulation (inhibition and augmentation) of complement receptor-3-mediated myelin phagocytosis. Neurobiol. Dis. 8, 504-512. doi: 10.1006/nbdi.2001.0383.
35. Rotshenker, S. (2003). Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease. J. Mol. Neurosci. 21, 65-72. doi: 10.1385/JMN:21:1:65.
36. Rotshenker, S. (2009). The role of Galectin-3/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease. J. Mol. Neurosci. 39, 99-103. doi: 10.1007/s12031-009-9186-7.
37. Rotshenker, S. (2011). Wallerian degeneration: the innate-immune response to traumatic nerve injury. J. Neuroinflammation 8:109. doi: 10.1186/1742-2094-8-109.
38. Ruiz, M., Sanchez, D., Correnti, C., Strong, R. K., and Ganfornina, M. D. (2013). Lipid-binding properties of human ApoD and Lazarillo-related lipocalins: functional implications for cell differentiation. FEBS J. 280, 3928-3943. doi: 10.1111/febs.12394.
39. Sanchez, D., Ortega-Cubero, S., Akerstrom, B., Herrera, M., Bastiani, M. J., and Ganfornina, M. D. (2008). Molecular interactions of the neuronal GPI-anchored lipocalin Lazarillo. J. Mol. Recognit. 21, 3-323. doi: 10.1002/jmr.902.
40. Shamash, S., Reichert, F., and Rotshenker, S. (2002). The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 22, 3052-3060.
41. Slobodov, U., Reichert, F., Mirski, R., and Rotshenker, S. (2001). Distinct inflammatory stimuli induce different patterns of myelin phagocytosis and degradation in recruited macrophages. Exp. Neurol. 167, 401-409. doi: 10.1006/exnr.2000.7559.
42. Spreyer, P., Schaal, H., Kuhn, G., Rothe, T., Unterbeck, A., Olek, K., et al. (1990). Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. EMBO J. 9, 2479-2484.
43. Steinhauer, J., Gijon, M. A., Riekhof, W. R., Voelker, D. R., Murphy, R. C., and Treisman, J. E. (2009). Drosophila lysophospholipid acyltransferases are specifically required for germ cell development. Mol. Biol. Cell 20, 5224-5235. doi: 10.1091/mbc.E09-05-0382.
44. Suresh, S., Yan, Z., Patel, R. C., Patel, Y. C., and Patel, S. C. (1998). Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D. J. Neurochem. 70, 242-251. doi: 10.1046/j.1471-4159.1998.70010242.x.
45. Thomas, E. A., George, R. C., and Sutcliffe, J. G. (2003). Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders. Prostaglandins Leukot. Essent. Fatty Acids 69, 421-427. doi: 10.1016/j.plefa.2003.08.014.
46. Tofaris, G. K., Patterson, P. H., Jessen, K. R., and Mirsky, R. (2002). Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J. Neurosci. 22, 6696-6703.
47. van der Laan, L. J., Ruuls, S. R., Weber, K. S., Lodder, I. J., Dopp, E. A., and Dijkstra, C. D. (1996). Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. J. Neuroimmunol. 70, 145-152. doi: 10.1016/S0165-5728(96)00110-5.
48. Vargas, M. E., and Barres, B. A. (2007). Why is Wallerian degeneration in the CNS so slow? Annu. Rev. Neurosci. 30, 153-179. doi: 10.1146/annurev.neuro.30.051606.094354.
49. Vogt, M., and Skerra, A. (2001). Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin or E-3M2H. J. Mol. Recognit. 14, 79-86. doi: 10.1002/1099-1352(200101/02)14:1<79::AID-JMR521>3.0.CO;2-4.
50. Yuan, J. S., Reed, A., Chen, F., and Stewart, C. N. Jr. (2006). Statistical analysis of real-time PCR data. BMC Bioinform. 7:85. doi: 10.1186/1471-2105-7-85.